U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Ketamine Hydrochloride Injection
Status: Currently in Shortage
»Date first posted: 02/16/2018
»Therapeutic Categories: Anesthesia

Expand all

Eugia US LLC (Reverified 07/17/2024)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 10 mg/1 mL (NDC 55150-438-10) Available Check wholesalers for inventory
Injection, 50 mg/1 mL (NDC 55150-439-10) Unavailable Intermittent availability expected Demand increase for the drug
Injection, 100 mg/1 mL (NDC 55150-440-10) Unavailable Intermittent availability expected Demand increase for the drug

Fresenius Kabi USA, LLC (Reverified 07/16/2024)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 10 mg/1 mL (NDC 65219-184-20) Available Check wholesaler inventory
Injection, 50 mg/1 mL (NDC 65219-188-10) Available Check wholesaler inventory

Gland Pharma Limited (Revised 07/15/2024)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Ketamine Hydrochloride, Injection, 10 mg/1 mL (NDC 25021-682-20) Available Distributed by Sagent Pharmaceuticals: 1-866-625-1618
Ketamine Hydrochloride, Injection, 50 mg/1 mL (NDC 25021-683-10) Available Distributed by Sagent Pharmaceuticals: 1-866-625-1618
Ketamine Hydrochloride, Injection, 100 mg/1 mL (NDC 25021-684-05) Available Distributed by Sagent Pharmaceuticals: 1-866-625-1618

Hikma Pharmaceuticals USA, Inc. (Revised 07/01/2024)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Ketamine HCl Injection, USP, Injection, 50 mg/1 mL (NDC 0143-9508-10) Unavailable Additional lots will be available in the June - July 2024 timeframe. Product will be made available as it is released. Demand increase for the drug
Ketamine HCl Injection, USP, Injection, 100 mg/1 mL (NDC 0143-9509-10) Available

Hospira, Inc., a Pfizer Company (Revised 07/15/2024)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 500 mg/5 mL (100 mg/mL) (NDC 0409-0040-10) Available
Ketamine Hydrochloride, Injection, 500 mg/10 mL (50 mg/mL) (NDC 0409-2053-10) Unavailable Next Delivery: January 2025; Estimated Recovery: March 2025 Demand increase for the drug

Par Pharmaceutical, Inc. (Reverified 07/15/2024)

Company Contact Information:
800-828-9393

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Ketalar, Injection, 10 mg/1 mL (NDC 42023-113-10) Available
Ketalar, Injection, 100 mg/1 mL (NDC 42023-115-10) Unavailable Recovery: TBD Shortage of an active ingredient
Ketalar, Injection, 50 mg/1 mL (NDC 42023-114-10) Unavailable Recovery: TBD Shortage of an active ingredient
Back to Top